These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3260662)

  • 41. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.
    Salvatore MF; Zhang JL; Large DM; Wilson PE; Gash CR; Thomas TC; Haycock JW; Bing G; Stanford JA; Gash DM; Gerhardt GA
    J Neurochem; 2004 Jul; 90(1):245-54. PubMed ID: 15198683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Release of [Met]enkephalin in the central nucleus of the amygdala is increased by application of potassium in the substantia nigra.
    Fayada C; Guibert B; Patey G; Cupo A; Chaminade M; Rossier J; Leviel V
    Neuropeptides; 1987 Jan; 9(1):9-17. PubMed ID: 3561724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Release of acetylcholinesterase from the guinea-pig cerebellum in vivo.
    Appleyard ME; Vercher JL; Greenfield SA
    Neuroscience; 1988 Apr; 25(1):133-8. PubMed ID: 3393274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of drugs interfering with sodium channels and calcium channels on the release of endogenous dopamine from superfused substantia nigra slices.
    Elverfors A; Jonason J; Jonason G; Nissbrandt H
    Synapse; 1997 Aug; 26(4):359-69. PubMed ID: 9215595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential cholinergic and non-cholinergic actions of acetylcholinesterase in the substantia nigra revealed by fasciculin-induced inhibition.
    Dajas F; Silveira R; Costa G; Castello ME; Jerusalinsky D; Medina J; Levesque D; Greenfield S
    Brain Res; 1993 Jul; 616(1-2):1-5. PubMed ID: 7689409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The involvement of 5-hydroxytryptamine in the release of dendritic dopamine from slices of rat substantia nigra.
    Williams J; Davies JA
    J Pharm Pharmacol; 1983 Nov; 35(11):734-7. PubMed ID: 6139455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo release of transmitters in the cat basal ganglia.
    Glowinski J
    Fed Proc; 1981 Feb; 40(2):135-41. PubMed ID: 6161843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.
    Kelly E; Jenner P; Marsden CD
    J Neurochem; 1985 Jul; 45(1):137-44. PubMed ID: 3923157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of GABA and L-glutamic acid on the potassium-evoked in vitro release of substance P- and neurokinin A-like immunoreactivities are different in the rat striatum and substantia nigra.
    Humpel C; Saria A
    Neurosci Lett; 1989 Oct; 105(1-2):159-63. PubMed ID: 2484728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Excitation of rat substantia nigra pars reticulata neurons by 5-hydroxytryptamine in vitro: evidence for a direct action mediated by 5-hydroxytryptamine2C receptors.
    Rick CE; Stanford IM; Lacey MG
    Neuroscience; 1995 Dec; 69(3):903-13. PubMed ID: 8596658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Presynaptic GABA autoreceptors on GABAergic nerve endings of the rat substantia nigra.
    Arbilla S; Kamal L; Langer SZ
    Eur J Pharmacol; 1979 Aug; 57(2-3):211-7. PubMed ID: 226375
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo release of adenosine from cat basal ganglia-studies with a push pull cannula.
    Barberis C; Guibert B; Daudet F; Charriere B; Leviel V
    Neurochem Int; 1984; 6(4):545-51. PubMed ID: 20488081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of GABA, dopamine, and substance P on the release of newly synthesized 3H-5-hydroxytryptamine from rat substantia nigra in vitro.
    Reubi JC; Emson PC; Jessell TM; Iversen LL
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 304(3):271-5. PubMed ID: 714184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons.
    Lantin le Boulch N; Truong-Ngoc NA; Gauchy C; Besson MJ
    Brain Res; 1991 Sep; 559(2):200-10. PubMed ID: 1794098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of gamma-hydroxybutyrate on the membrane properties of guinea-pig pars compacta neurons in the substantia nigra in vitro.
    Harris NC; Webb C; Greenfield SA
    Neuroscience; 1989; 31(2):363-70. PubMed ID: 2797441
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NMDA regulation of dopamine release from proximal and distal dendrites in the cat substantia nigra.
    Gauchy C; Desban M; Glowinski J; Kemel ML
    Brain Res; 1994 Jan; 635(1-2):249-56. PubMed ID: 8173961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subdivisions of the primate substantia nigra pars compacta detected by acetylcholinesterase histochemisty.
    Jimenez-Castellanos J; Graybiel AM
    Brain Res; 1987 Dec; 437(2):349-54. PubMed ID: 2449266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo release of substance P in the cat substantia nigra.
    Michelot R; Leviel V; Torrens Y; Glowinski J; Chéramy A
    Neurosci Lett; 1979 Dec; 15(2-3):141-6. PubMed ID: 93729
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro.
    Rice ME; Cragg SJ; Greenfield SA
    J Neurophysiol; 1997 Feb; 77(2):853-62. PubMed ID: 9065854
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A possible pacemaker mechanism in pars compacta neurons of the guinea-pig substantia nigra revealed by various ion channel blocking agents.
    Harris NC; Webb C; Greenfield SA
    Neuroscience; 1989; 31(2):355-62. PubMed ID: 2552348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.